CD34 and cancer: CD34+ SFCs have been proposed as the progenitors of fibroblastic/myofibroblastic and lipomatous tumors25 since benign or low-grade malignant tumors of these types constantly express CD3425, 26 while their malignant counterparts frequently lack CD34 expression15–21, 27.